A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far
Most prevalent neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and multiple sclerosis are heterogeneous in their clinical profiles and underlying pathophysiology, although they typically share the presence of cognitive impairment that worsens sign...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/11/5/528 |
| _version_ | 1797536841141846016 |
|---|---|
| author | Stefano Lasaponara Fabio Marson Fabrizio Doricchi Marco Cavallo |
| author_facet | Stefano Lasaponara Fabio Marson Fabrizio Doricchi Marco Cavallo |
| author_sort | Stefano Lasaponara |
| collection | DOAJ |
| description | Most prevalent neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and multiple sclerosis are heterogeneous in their clinical profiles and underlying pathophysiology, although they typically share the presence of cognitive impairment that worsens significantly during the course of the disease. Viable pharmacological options for cognitive symptoms in these clinical conditions are currently lacking. In recent years, several studies have started to apply Computerized Cognitive Training (CCT) and Virtual Reality (VR) tools to try and contrast patients’ cognitive decay over time. However, no in-depth literature review of the contribution of these promising therapeutic options across main neurodegenerative diseases has been conducted yet. The present paper reports the state-of-the-art of CCT and VR studies targeting cognitive impairment in most common neurodegenerative conditions. Our twofold aim is to point out the scientific evidence available so far and to support health professionals to consider these promising therapeutic tools when planning rehabilitative interventions, especially when the access to regular and frequent hospital consultations is not easy to be provided. |
| first_indexed | 2024-03-10T12:06:32Z |
| format | Article |
| id | doaj.art-3d3e2323f02344c585d2e9dd2b9ff90a |
| institution | Directory Open Access Journal |
| issn | 2076-3425 |
| language | English |
| last_indexed | 2024-03-10T12:06:32Z |
| publishDate | 2021-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Brain Sciences |
| spelling | doaj.art-3d3e2323f02344c585d2e9dd2b9ff90a2023-11-21T16:30:26ZengMDPI AGBrain Sciences2076-34252021-04-0111552810.3390/brainsci11050528A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So FarStefano Lasaponara0Fabio Marson1Fabrizio Doricchi2Marco Cavallo3Department of Psychology, Sapienza University of Rome, 00185 Rome, ItalyResearch Institute for Neuroscience, Education and Didactics, Fondazione Patrizio Paoletti, 06081 Assisi, ItalyDepartment of Psychology, Sapienza University of Rome, 00185 Rome, ItalyFaculty of Psychology, eCampus University, 22060 Novedrate, ItalyMost prevalent neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and multiple sclerosis are heterogeneous in their clinical profiles and underlying pathophysiology, although they typically share the presence of cognitive impairment that worsens significantly during the course of the disease. Viable pharmacological options for cognitive symptoms in these clinical conditions are currently lacking. In recent years, several studies have started to apply Computerized Cognitive Training (CCT) and Virtual Reality (VR) tools to try and contrast patients’ cognitive decay over time. However, no in-depth literature review of the contribution of these promising therapeutic options across main neurodegenerative diseases has been conducted yet. The present paper reports the state-of-the-art of CCT and VR studies targeting cognitive impairment in most common neurodegenerative conditions. Our twofold aim is to point out the scientific evidence available so far and to support health professionals to consider these promising therapeutic tools when planning rehabilitative interventions, especially when the access to regular and frequent hospital consultations is not easy to be provided.https://www.mdpi.com/2076-3425/11/5/528Alzheimer’s diseasecognitive impairmentfrontotemporal dementiamultiple sclerosisneuropsychologyParkinson’s disease |
| spellingShingle | Stefano Lasaponara Fabio Marson Fabrizio Doricchi Marco Cavallo A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far Brain Sciences Alzheimer’s disease cognitive impairment frontotemporal dementia multiple sclerosis neuropsychology Parkinson’s disease |
| title | A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far |
| title_full | A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far |
| title_fullStr | A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far |
| title_full_unstemmed | A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far |
| title_short | A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far |
| title_sort | scoping review of cognitive training in neurodegenerative diseases via computerized and virtual reality tools what we know so far |
| topic | Alzheimer’s disease cognitive impairment frontotemporal dementia multiple sclerosis neuropsychology Parkinson’s disease |
| url | https://www.mdpi.com/2076-3425/11/5/528 |
| work_keys_str_mv | AT stefanolasaponara ascopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT fabiomarson ascopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT fabriziodoricchi ascopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT marcocavallo ascopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT stefanolasaponara scopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT fabiomarson scopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT fabriziodoricchi scopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar AT marcocavallo scopingreviewofcognitivetraininginneurodegenerativediseasesviacomputerizedandvirtualrealitytoolswhatweknowsofar |